切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 58 -61. doi: 10.3877/cma.j.issn.1674-0807.2020.01.014

所属专题: 文献

综述

治疗性缩乳成形术在乳房肥大患者乳腺癌保留乳房手术中的应用
金立亭1, 冯尧军1,()   
  1. 1. 430079 武汉,湖北省肿瘤医院乳腺中心
  • 收稿日期:2017-09-25 出版日期:2020-02-01
  • 通信作者: 冯尧军
  • 基金资助:
    湖北省自然科学基金资助项目(2019CFB833)

Oncotherapeutic mammaplasty for breast cancer patients with breast hypertrophy

Liting Jin1, Yaojun Feng1()   

  • Received:2017-09-25 Published:2020-02-01
  • Corresponding author: Yaojun Feng
引用本文:

金立亭, 冯尧军. 治疗性缩乳成形术在乳房肥大患者乳腺癌保留乳房手术中的应用[J/OL]. 中华乳腺病杂志(电子版), 2020, 14(01): 58-61.

Liting Jin, Yaojun Feng. Oncotherapeutic mammaplasty for breast cancer patients with breast hypertrophy[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2020, 14(01): 58-61.

乳房肥大(巨乳症)合并乳腺癌的患者接受传统保留乳房治疗后往往会出现难以接受的美容并发症。乳房肥大的乳腺癌患者行保留乳房手术后,放射治疗常常导致乳房外形不佳,巨大乳房又会影响放射治疗的剂量分布和定位,影响放射治疗效果。治疗性缩乳成形术可以使乳房肥大的乳腺癌患者达到保留乳房和美容成形的双重效果。笔者从治疗性缩乳成形术的肿瘤治疗安全性、并发症以及手术方式等方面对其进行全面总结。既往研究结果表明,治疗性缩乳成形术不仅可以提供安全的肿瘤治疗方式,还可以防止或减轻合并症,成为乳房肥大的乳腺癌保留乳房患者的有利选择。

[1]
Dundas KL, Atyeo J, Cox J. What is a large breast? Measuring and categorizing breast size for tangential breast radiation therapy[J]. Australas Radiol, 2007, 51(6):589-593.
[2]
Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer[J]. Int J Radiat Oncol Biol Phys, 1995, 31(4): 753-764.
[3]
Moody AM, Mayles WP, Bliss JM, et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity[J]. Radiother Oncol, 1994, 33(2): 106-112.
[4]
Kronowitz SJ, Feledy JA, Hunt KK, et al. Determining the optimal approach to breast reconstruction after partial mastectomy[J]. Plast Reconstr Surg, 2006, 117(1): 1-11.
[5]
McCulley SJ, Macmillan RD. Planning and use of therapeutic mammoplasty—Nottingham approach[J]. Br J Plast Surg, 2005, 58(7): 889-901.
[6]
Clough KB, Baruch J. Plastic surgery and conservative treatment of breast cancer. Indications and results[J]. Ann Chir Plast Esthet, 1992, 37(6): 682-692.
[7]
Shestak, KC, Johnson RR, Greco RJ, et al. Partial mastectomy and breast reduction as a valuable treatment option for patients with macromastia and carcinoma of the breast[J]. Surg Gynecol Obstet, 1993, 177(1): 54-56.
[8]
Lyngholm CD, Christiansen PM, Damsgaard TE, et al. Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG)[J]. Acta Oncol, 2013, 52(2): 259-269.
[9]
Juneja P, Bonora M, Haviland JS, et al. Does breast composition influence late adverse effects in breast radiotherapy? [J]. Breast, 2016, 26: 25-30.
[10]
Gray JR, McCormick B, Cox L, et al. Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome[J]. Int J Radiat Oncol Biol Phys, 1991, 21(2): 347-354.
[11]
Waljee JF, Hu ES, Ubel PA, et al. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life[J]. J Clin Oncol, 2008, 26(20): 3331-3337.
[12]
Mello AA, Domingos NA, Miyazaki MC. Improvement in quality of life and self-esteem after breast reduction surgery[J]. Aesthetic Plast Surg, 2010, 34(1): 59-64.
[13]
Singh KA, Losken A. Additional benefits of reduction mammaplasty: a systematic review of the literature[J]. Plast Reconstr Surg, 2012, 129(3): 562-570.
[14]
Asgeirsson KS, McCulley SJ, Pinder SE, et al. Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy[J]. Eur J Cancer, 2003, 39(17): 2462-2469.
[15]
Palmieri B, Benuzzi G, Costa A, et al. Breast reduction and subsequent cancer: a prophylactic perspective[J]. Breast, 2006, 15(4): 476-481.
[16]
Fitoussi AD, Berry MG, Fama F, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [J]. Plast Reconstr Surg, 2010, 125(2): 454-462.
[17]
Grubnik A, Benn C, Edwards G. Therapeutic mammaplasty for breast cancer: oncological and aesthetic outcomes[J]. World J Surg, 2013, 37(1): 72-83.
[18]
Schaverien MV, Raine C, Majdak-Paredes E, et al. Therapeutic mammaplasty--extending indications and achieving low incomplete excision rates[J]. Eur J Surg Oncol, 2013, 39(4): 329-333.
[19]
Macmillan RD, James R, Gale KL, et al. Therapeutic mammaplasty[J]. J Surg Oncol, 2014, 110(1): 90-95.
[20]
Rosenkranz KM, Ballman K, McCall L, et al. The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: an initial report from ACOSOG Z11102 (Alliance) trail[J]. Ann Surg Oncol, 2018, 25(10): 2858-2866.
[21]
Meattini I, Pasinetti N, Meduri B, et al. A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)[J]. Radiother Oncol, 2019, 131: 208-214.
[22]
Kabir SA, Stallard S, Weiler-Mithoff E, et al. Six-year follow-up of patients treated with oncoplastic reduction mammoplasty: A cohort study[J]. Int J Surg, 2016, 26: 38-42.
[23]
Piper ML, Esserman LJ, Sbitany H, et al. Outcomes following oncoplastic reduction mammoplasty: a systematic review[J]. Ann Plast Surg, 2016, 76 Suppl 3: S222-226.
[24]
McIntosh J, O’Donoghue JM. Therapeutic mammaplasty--a systematic review of the evidence[J]. Eur J Surg Oncol, 2012, 38(3): 196-202.
[25]
Brown RH, Siy R, Khan K, et al. The superomedial pedicle wise-pattern breast reduction: reproducible, reliable, and resilient[J]. Semin Plast Surg, 2015, 29(2): 94-101.
[26]
McKissock PK. Reduction mammaplasty with a vertical dermal flap[J]. Plast Reconstr Surg, 1972, 49(3): 245-252.
[27]
Copeland-Halperin LR, Smith L, Copeland M. Re-evaluating the Lejour Technique for Breast Reduction in Patients with Macromastia[J]. Plast Reconstr Surg Glob Open, 2018, 6(5): e1783.
[28]
Silverstein MJ, Mai T, Savalia N, et al. Oncoplastic breast conservation surgery: the new paradigm[J]. J Surg Oncol, 2014, 110(1): 82-89.
[29]
柳林,陈晰,郭宝良,等. 保留乳房手术切缘的相关问题[J/CD]. 中华乳腺病杂志(电子版),2017,11(3):182-185.
[30]
Sorin T, Fyad JP, Delay E, et al. Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients[J]. Breast, 2015, 24(3): 272-277.
[31]
Slezak S, Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy[J]. Plast Reconstr Surg, 2011, 127(2): 525-530.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?